| Fiscal Year End | Company Status | Exempt Flag |
| December 31 | Trading | N |
|
|
|
|
|
| Incorporation Locations |
| Inc. Date | Expiry Date | Country | Region | Description |
| 26/Mar/2012 | | Canada | Alberta | |
|
|
| Exchange Filing Office |
| Location |
| Calgary Regional Service Office |
|
|  |
| Business Type(s) |
| Primary/Secondary | Business Type | Details |
| Primary
| Consumer Products - Biotechnology/Pharmaceuticals
| News Release January 12, 2015-Hemostemix is a public clinical-stage company that develops and commercializes innovative blood-derived cell therapies for medical conditions not adequately addressed by current treatments.
|
|
|
| Securities |
| Symbol | Security Name | Market | Status |
| HEM | Hemostemix Inc. | TSX Venture | TRADING |
|
|
| Name History | From | To |
| Hemostemix Inc. | 27/Nov/2014 | Present |
|
|
| Company Facts Reconciliation |
| Subject | Date Returned |
| Spring 2015 CFR | Not Received |
|
|
|
|
|
